Research Hub
- Megan McCue
- Apr 27
- 3 min read
Updated: 2 days ago

***THIS SECTION IS CURRENTLY IN PROGRESS. PLEASE BE PATIENT***
The following is a growing list of medical research related to iatrogenic botulism.
**HINT: It is important to always look for the funding source when looking at any research pertaining to botulinum toxin injections. This is a powerful, $11 billion dollar industry, and thus much of the research is industry-funded. Companies that make BoNT products (and fund a lot of the research for new uses of these products) include Allergan/Abbvie, Galderma/Ipsen, Merz Pharmaceuticals.
Categories:
Understanding Botulism
Iatrogenic Botulism Research
A review of Iatrogenic Botulism
Review on IB, signs and symptoms, treatment, etc
Clinical analysis of 86 botulism cases caused by cosmetic injections
Helpful case studies that report some of the most common symptoms reported by IB patients
Important paper for understanding the wide range of PNS and CNS symptoms that can occur post-botulinum toxin injections
Severe nervous system complications after botulinum toxin type a therapy
Important paper for understanding CNS conditions that can occur after BoNT injections; includes reviews of neurological impairments reported to the FDA post-BoNT injections
Analysis of clinical challenges and prognostic risk factors for 195 cases of iatrogenic botulism in China Large study that details frequent characterstics of iatrogenic botulism, as well as prognostic factors. Bottom line: early antitoxin administration is critical.
Frontal alopecia following BoNT injections research article on the type of hair loss that can occur post-BoNT injections
Complications of Cosmetic Botulinum Toxin A Injections to the Upper Face: A Systematic Review and Meta-Analysis meta-analysis on complications; pay close attention to treatment vs placebo rates of complications
Quantitative and Qualitative Analysis of Individual Experiences Post Botulinum Toxin Injection - United Kingdom Survey - survey of BoNT consumers; most common reported symptoms after injections included anxiety, panic attacks, headaches, dizziness, and brain fog
Real-life prognosis of neurological complications of botulinum toxin: A nationwide pharmacovigilance study of adverse drug reactions reported in France between 1994 and 2020. A study funded by Merz Pharmaceuticals (makers of Xeomin), investigating incidence rates of neurological complications following BoNT injections
The Possible Adverse Effects of Intramuscular Botulinum Toxin Injections and their Management
Selected Iatrogenic Botulism Case Studies
Dysphagia and Muscle Weakness Caused by Botulinum Toxin Poisoning after Cosmetic Injection (2025)
From Beauty to Botulism: A Case Report Highlighting the Rare Risk of Botox Administration (2024)
Iatrogenic Botulism after botulinum toxin type A: Five cases (2024)
Severe Botulism after Intragastric Botulinum Toxin-A Injection: A Case Series (2024)
Iatrogenic Botulism: A Case Treated With Botulinum Antitoxin (2023)
Iatrogenic botulism – a possible cause of generalised muscular weakness in child (2020)
Case of iatrogenic botulism after botulinotherapy in clinical practice
Rapidly Progressive Muscle Paralysis and Acute Respiratory
Failure Following Endoscopic Botulinum Toxin Injection (2016)
Iatrogenic Botulism After Botulinum Toxin Type A Injections (2010)
Iatrogenic Botulism in a Child With Spastic Quadriparesis (2007)
BoNT's Effects on the CNS
Transsynaptic inhibition of spinal transmission by A2 botulinum toxin
Control of Autophagosome Axonal Retrograde Flux by Presynaptic Activity Unveiled Using Botulinum Neurotoxin Type A
Botulinum Neurotoxins in Central Nervous System: An Overview from Animal Models to Human Therapy.
Botulinum neurotoxin A impairs neurotransmission following retrograde transynaptic transport.
Comments